Targeted CRM1-inhibition perturbs leukemogenic NUP214 fusion proteins and exerts anti-cancer effects in leukemia cell lines with NUP214 rearrangements
A. Mendes, R. Juehlen, V. Martinelli, B. Fahrenkrog
This study shows that CRM1 inhibition disrupts NUP214 fusion proteins in leukemia cell lines, leading to anti-cancer effects by altering nuclear localization and cell viability.
bioRxiv · Apr 23, 2020Cancer Biology